Chemical Structure (Lidocaine 01)
Lidocaine Hydrochloride Injection, Solution
Product Images NDC 0409-4275
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0409-4275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lidocaine 01a
Hospira Logo (Lidocaine 02)
Principal Display Panel (5 mL Ampule Label)
This is a description for a medication called Lidocaine HCI Injection, with a concentration of 50mg/5ml, distributed by Hospira, Inc. It is a prescription-only medication, comes in a 5ml container, and is preservative-free. The lot number is M.L.No. 08/VP/AP/2013/F/G, and the drugs were distributed in 08/2013.*
Principal Display Panel (5 mL Ampule Cello Pack Label)
This is a 5mL single-dose ampoule of 1% Lidocaine HCl injection, USP, for infiltration and nerve block including epidural and caudal. It contains 10mg anhydrous lidocaine hydrochloride and 7mg sodium chloride per mL. It may contain sodium hydroxide and/or hydrochloric acid for pH adjustment, has a pH range of 5.0-7.0, and a usual dosage, which is specified in the insert. It is distributed by Hospira, Inc. and made in Spain. The NDC and lot number are also provided.*
Principal Display Panel (2 mL Ampule Label)
This is a description of medication named Lidocaine HC. It is an injection solution with a concentration of 1% of mmg/mL. The medication comes in a 2mL preservative-free vial and its NDC number is 0409-4713-72. The medication is distributed by Hospira, Inc. and is only available with a prescription.*
Principal Display Panel (5 mL Ampule Label)
This is a prescription drug labeled Lidocaine HCI in Injection, USP form. It comes in a bottle of 5mL with a strength of 50mg/5mL (10mg/mL). It is labeled preservative-free and is for Rx use only. Additionally, there are details regarding lot and expiration dates on the label.*
Principal Display Panel (2 mL Ampule Label)
This is a product label for a prescription medication called Lidocaine HCI Injection, USP with a concentration of 20 mg/2 mL, which is distributed by Hospira, Inc. It is preservative-free and only available with a prescription.*
Principal Display Panel (2 mL Ampule Carton)
This is a description of a Lidocaine HCl Injection, USP drug provided by Hospira, Inc. The box contains 10 single-dose ampuls of 2 mL each with a concentration of 20 mg/2 mL (10 mg/mL). The drug is indicated for infiltration and nerve block, including epidural and caudal. It is preservative-free and may contain sodium hydroxide and/or hydrochloric acid for pH adjustment. The usual dosage may vary and is provided in the insert. The drug should be stored at a temperature of 20-25°C.*
Principal Display Panel (50 mL Vial Label)
This is a description of a single-dose preservative-free injection containing Lidocaine HCI for infiltration technique, percutaneous injection, and intravenous regional anesthesia. The injection is distributed by Hospira, Inc and each 50 mL dose contains 250 mg/50 mL (5mg/mL) of Lidocaine HCI. Each milliliter of the injection contains lidocaine hydrochloride, anhydrous s, and NaCl 8mg, and it may contain HCl and/or NaOH, if required, for pH adjustment. The pH level is 6.5 (5.0 to 7.0) and it is sterile, nonpyrogenic. The usual dosage is not specified. The unused portion should be discarded and the injection should be stored at a controlled temperature of 20 to 25°C (68 to 77°F) as indicated by USP. The lot number and expiration date are mentioned.*
Principal Display Panel (50 mL Vial Tray)
Principal Display Panel (30 mL Vial Label)
This is a description of a single-dose injection of Lidocaine HCI, which is used for infiltration and nerve block, including epidural and caudal. It is sterile and non-pyrogenic and each millilitre (mL) contains 10mg of lidocaine HCl and 7mg of NaCl. The solution may contain hydrochloric acid (HCI) and/or sodium hydroxide (NaOH) for pH adjustment, and it has a pH level of 6.5 (ranging from 5.0 to 7.0). The dosage instructions are detailed in the insert, and any unused portion should be discarded. The injection should be stored between 20 and 25°C (68 to 77°F). Note that the label includes Hospira's contact information and a LOT/EXP number.*
Principal Display Panel (30 mL Vial Tray)
This is information about a prescription medication in a single-dose vial. It contains lidocaine hydrochloride and sodium chloride. Each vial is preservative free and sterile. The manufacturer is Hospira, Inc in Lake Forest, IL. The dosage instructions are not provided. There is some numerical information, but it is not clear what it refers to.*
Principal Display Panel (20 mL Ampule Label)
This is a 20 mL single-dose container of preservative-free Lidocaine solution (15 mg/mL) distributed by Hospira for infiltration and nerve block, including epidural and caudal. Each mL contains lidocaine hydrochloride and sodium chloride. The solution may contain sodium hydroxide and/or hydrochloric acid for pH adjustment with a pH range of 5.0 to 7.0. This solution is sterile, nonpyrogenic, and has a usual dosage, which is referenced in the insert. It needs to be stored at 20 to 25°C (68 to 77°F). The container has an NDC of 0409-4776-10 and lot number and expiration date.*
Principal Display Panel (20 mL Ampule Carton)
This is a description of a medication contained in a 20mL single-dose ampule used for epidural and caudal blockade, as well as infiltration and nerve block. The medication is an Injection, USP with 300mg/20mL, which is Lidocaine Hydrochloride 15 mg/mL in Sodium Chloride. The pH is adjusted to 6.5 with sodium hydroxide and/or hydrochloric acid, and the medication is sterile and nonpyrogenic. It is distributed by Hospira, Inc. and should be stored between 68 to 77°F. The usual dosage should be seen in the insert. The package is Rx only and contains preservatives.*
Principal Display Panel (2 mL Ampule Label)
This is a product description for a single-dose injection of Lidocaine HCI, a local anesthetic, containing 40mg/2mL solution. It is preservative-free and available by prescription only. The product is distributed by Hospira, located in Lake Forest, IL. The lot number and expiration date are provided.*
Principal Display Panel (2 mL Ampule Cello Pack)
This is a description of a prescription drug in the form of 2mL single-dose ampuls with NDC 0409-4282-25, which may be used for infiltration, peripheral or sympathetic nerve blocks, epidural and caudal blocks. The drug is preservative-free and contains 40mg/2mL of lidocaine hydrochloride, as well as sodium chloride. It also may contain HCl and/or NaOH for pH adjustment and has a pH of 6.5 (5.0 to 7.0). The dosage is indicated in the insert and it is stored at a controlled room temperature of 20 to 25°C (68 to 77°F). However, it cannot be used for spinal use. The product is distributed by Hospira, Inc. and has an NDC of 0409-4282-25.*
Principal Display Panel (10 mL Ampule Label)
This is a prescription drug that comes in a pre-filled syringe containing 10 mL of lidocaine HCI (20 mg/mL) used for infiltration and nerve block purposes including epidural and caudal. It is sterile, nonpyrogenic and pH adjusted to 6.5. The usual dosage is specified in the insert and any unused contents should be discarded. It is distributed by Hospira Inc. and should be stored at between 20 to 25°C. There is a lot number and expiry date specified for the product.*
Principal Display Panel (10 mL Ampule Carton)
This is a description of a 10mL single-dose ampule containing Lidocaine HCI Injection. It is preservative-free and can be used for infiltration and nerve blocks, including epidural and caudal. It contains 200 mg/10 mL (20 mg/mL). The usual dosage should be seen in the insert, and the discard should be mandatory after use. Possible contents are hydrochloric acid and/or sodium hydroxide for pH adjustment. The Hospira company in the US distributed it. The sample contains some unreadable characters, but overall it is a description of a Lidocaine HCI Injection ampule.*
Principal Display Panel (400 mg/20 mL Vial Label)
This appears to be a product label for an injection solution with the name NDC 0409-4277-16. It is a 20 mL solution for infiltration and nerve block, containing lidocaine hydrochloride as the active ingredient. It is intended for sterile, nonpyrogenic use under medical supervision, with a recommended dosage of 400 mg/20 mL. The label includes information about its storage conditions, pH level, and preservatives. The product is distributed by Hospira, Inc., based in Lake Forest, IL, USA.*
Principal Display Panel (400 mg/20 mL Vial Tray)
This is a description for an injection named Lidoca. It contains 20 mg of lidocaine hydrochloride, 6 mg of sodium chloride, and 1 mg of methylparaben used as a preservative per mL. It may also have hydrochloric acid and/or sodium hydroxide to adjust the pH level which is 6.5 (5010 7.0). It is distributed by Hospira, Inc, Lake Forest, IL60045 USA. It can be used for infiltration and nerve block. Not applicable for epidural and caudal use. Lidoca contains preservatives. The package has 20 mL of multiple-dose flip-top vials. The usual dosage is given with instructions which can only be followed if the package is undamaged and sealed. Overall, it is a nonpyrogenic injection.*
Principal Display Panel (1000 mg/50 mL Vial Label)
This is a 50 mL injection of Lidocaine HCI, containing 2% of the medication, with a total of 1000 mg. It is intended for infiltration and nerve blocking only, but not for epidural or caudal use, and contains a preservative. The medication also contains 20 mg of lidocaine hydrochloride anhydrous, 6 mg of sodium chloride, and 1 mg of methylparaben. It may also contain HCl and/or NaOH for pH adjustment, and is sterile and non-pyrogenic. Recommended dosage is provided in the insert. This product should be stored at a temperature between 20 to 25°C (68 to 77°F). It is distributed by Hospira, Inc. in Lake Forest, IL.*
Principal Display Panel (1000 mg/50 mL Vial Tray)
A prescription-only 50 mL multiple-dose flip-top vial containing 1000mg/50ml with a concentration of 20mg/mL from Hospira. The vial should be stored at a temperature of 20 to 25°C. The cover needs to be removed from the plastic vial and the stopper should be cleaned with antiseptic before use. The other information available on the package is incomplete or not legible.*
Principal Display Panel (200 mg/20 mL Vial Label)
This is a description of Lidocaine HCI Injection, USP in 200mg/20ml concentration (10mg/mL). The product is intended for infiltration and nerve block but not for epidural and caudal use. It contains a preservative and each mL has 10mg of Lidocaine hydrochloride, anhydrous and other components such as Sodium chloride and Methylparaben. The pH ranges from 5.0 to 7.0 and the product is sterile and nonpyrogenic. The storage temperature is between 20°C to 25°C (68°F to 77°F). This product is distributed by Hospira, located in Lake Forest, IL, USA.*
Principal Display Panel (200 mg/20 mL Vial Tray)
Each mL of the product contains lidocaine hydrochloride, anhydrous, along with sodium chloride, gentamicin sulfate, and a preservative. The usual dosage information is available in the supplied insert. It is only safe to use the product if the seal is intact and the solution is clear. The pH level of the solution is 6.5 and it may include hydrochloric acid or hydroxide for pH adjustment. The source of the text is a label of the product distributed by Heraeus Medical LLC.*
Principal Display Panel (500 mg/50 mL Vial Label)
This is a medication with NDC number 0409-4276-17 used for infiltration and nerve block. It contains Lidocaine HCl as the main ingredient along with preservatives, sodium chloride, and methylparaben. It is not to be used for epidural and caudal. It should be stored between 20-25°C. The manufacturer is Hospira Inc located in Lake Forest, Illinois. Lot number and expiry date provided.*
Principal Display Panel (500 mg/50 mL Vial Tray)
Each mL of the solution contains 10mg of anhydrous cocaine hydrochloride, 7mg of sodium chloride, and 1mg of methylparaben. It's sterile and non-pyrogenic. The solution may contain hydrochloric acid and/or sodium hydroxide used for adjusting pH. The product insert should be consulted for the usual dosage. Made in Spain and distributed by Hospira, Inc. in the USA. The rest of the text is not readable.*
Principal Display Panel (250 mg/50 mL Vial Label)
This is a description of a medication called 0.5% Lidocaine HCI that is distributed by a company called Hospira. The medication is meant for infiltration and nerve block and comes in a 50 mL multiple dose bottle with 250mg/5mL. The medication has an NDC code of 0409-4275-16 and an injection number of 9270. There is a lot number and expiration date provided for tracking purposes.*
Principal Display Panel (250 mg/50 mL Vial Tray)
50 mL Multiple-dose Fliptop Vials containing 0.5% Lidocaine HCl for numbing and pain relief purposes. It contains a preservative and is at a strength of 250 mg/50mL (5 mg/mL). The NDC code is 0409-4275-01 and it is for Rxonly use. The text has some formatting issues and some parts are not understandable.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
